跳至主要内容
临床试验/EUCTR2021-000559-38-DK
EUCTR2021-000559-38-DK进行中(未招募)1 期

The effect of intravesical Lidocaine solution versus placebo as anesthesia prior to intravesical injection of onabotulinum toxin A. A randomized, double-blind, placebo controlled cross-over study

Herlev and Gentofte University Hospital, Department of Obstetrics and Gynecology0 个研究点目标入组 50 人开始时间: 2021年11月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Female, age =18 years
  • Admitted to treatment with BTX-A injections at the Urogynecological Clinic at Herlev Hospital due to UUI
  • Able to read and understand Danish
  • The female accepts to receive BTX-A injection as an outpatient treatment without the option of receiving sedative drugs
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • BTX-A allergy
  • Neurological disorder that may affect bladder function (e.g. Multiple sclerosis or spinal cord inju-ry)
  • Neurological disorder with neuromuscular transmission failure (i.e. Mystenia Gravis)
  • Positive urine culture and symptoms of urinary tract infection prior to treatment
  • Any other bladder pathology at the time of cystoscopy if identified (includes trauma, stones, tu-mor)
  • Pregnancy/breastfeeding women

研究者

发起方
Herlev and Gentofte University Hospital, Department of Obstetrics and Gynecology

相似试验

The effect of bladder installed local anesthetic... | 临床试验